throbber
THE COVALENT STRUCTURE OF
`AN ENTIRE -yG IMMUNOGWBULIN MOLECULE*
`
`BY GERALD M. EDELMAN, BRUCE A. CUNNINGHAM, w. EINAR GALL,
`PAUL D. GO'ITLIEB, URS RUTISHAUSER, AND MYRON J. WAXDAL
`
`THE ROCKEFELLER UNIVERSITY
`
`Communicated by Theodore SMdlovsky, March 21, 1969
`
`Abstract.-The complete amino acid sequence of a human -yGl immunoglobu­
`lin (Eu) has been determined and the arrangement of all of the disulfide bonds
`has been established. Comparison of the sequence with that of another myeloma
`protein (He) suggests that the variable regions of heavy and light chains are
`homologous and similar in length. The constant portion of the heavy chain con­
`tains three homology regions each of which is similar in size and homologous to
`the constant region of the light chain. Each variable region and each constant
`homology region contains one intra.chain disulfide bond. The half-cystines
`participating in the interchain bonds are all clustered within a stretch of ten
`residues at the middle of the heavy chains.
`These data support the hypothesis that immunoglobulins evolved by gene
`duplication after early divergence of V genes, which specified antigen-binding
`functions, and C genes, which specified other functions of antibody molecules.
`Each polypeptide chain may therefore be specified by two genes, V and C, which
`are fused to form a single gene (translocation hypothesis). The internal homol­
`ogies and symmetry of the molecule suggest that homology regions may have
`similar three-dimensional structures each consisting of a compact domain which
`contributes to at least one active site (domain hypothesis). Both hypotheses
`are in accord with the linear regional differentiation of function in antibody
`molecules.
`
`Antibodies or immunoglobulins can interact with a wide range of different
`antigenic determinants and, after specific binding to an antigen, they play a
`fundamental part in physiological functions of the immune response. The
`specificity of antigen binding depends ultimately upon amino acid sequences of
`the variable or V regions of antibody molecules. It is the diversity of these
`sequences which results in the range of specificities required for a selective im­
`mune response. In contrast, other regions of the antibody molecule have rela­
`tively constant sequences and are responsible for physiological functions. Like
`enzymes, these C regions appear to have evolved for a restricted set of interac­
`tions. This unusual picture of intramolecular differentiation has emerged from
`studies of the structure of immunoglobulins from different animal species. I To
`date, only portions of immunoglobulin molecules have been suhjected to amino
`acid sequence determination.
`We now report the amino acid 8equeuce of an entire human -yGl immuno­
`globulin (molecular weight 150,000), the location of all disulfide bonds, the
`arrangement of light and heavy chains, and the length of the heavy chain V
`region.
`
`78
`
`1 of 8
`
`BI Exhibit 1091
`
`

`

`VoL. 63, 1969
`
`BIOCHEMISTRY: EDELMAN ET AL.
`
`79
`
`MaterWls and Metlw<U.-The isolation of the myeloma protein Eu2 and the preparation
`of its CNBr fragment53• 4 have he.en described. Similar methods were used for the isola­
`tion of the -yG 1 myeloma protein He and for the preparat.ion of its CNBr fragments.
`We have previously described the methods used for enzymatic digestion with trypsin,
`chymotrypsin, and pepsin, gel filtmtion, ion exchange chromatography, high voltage paper
`electrophoresis, determination of NHrterminal and COOR-terminal residues, amino acid
`analysis, and determination of amino acid sequences by the dansyl-Edman procedure. •-e
`The positions of glutamine and asparagine were assigned9 by determining the electro­
`phoretic mobility of peptides and by amino acid analysis of the peptides after enzymatic
`hydrolysis. The half-eystinyl residues contributing to each intrachain disulfide bond
`were determined 10 using the diagonal electrophoresis method.11
`Results.-The organization of the whole molecule is shown in Figure 1; an un­
`equivocal proof of the arrangement of the two identical light chains and two
`identical heavy chains has already been given.4 Each light chain is linked to its
`neighboring heavy chain by a disulfide bond between corresponding half-
`
`Fob(t)
`
`Fob(t)
`
`Heovy
`choin
`
`Light
`choon
`
`COOi<
`COOH
`Fc(t)
`
`FIG. 1.---0ver-all arrangement of chains and disulfide bonds of "YGl immunoglobulin
`Eu. Half-cystinyl residues are numbered I-XI; numbers I-V designate corresponding
`residues in light and heavy chains. PCA: pyrollidooecarboxylic acid. CHO: carbo­
`hydrate. "Fab(t)" and "Fc(t)" refer to fragments produced by trypsin, which cleaves
`the heavy chain as indicated by dashed lines above half-cystinyl residues VI. VH, VL:
`variable regions of heavy and light chains, CL: constant region of light chain. CHl,
`Ca2, Ca3: homology regions comprising Ca or constant region of heavy chain.
`
`cystines V. Half-cystines VI and VII form bonds linking the half-molecules via
`the heavy chains. Trypsin cleaves the molecule at lysyl residue 222 to form two
`Fab(t) and one Fc(t) fragments.2• 5
`There are several strikingly linear arrangements in the primary structure.
`From their amino termini to half-cystines V, the light and heavy chains can be
`aligned or put in register. The intrachain disulfide bonds are linearly and period­
`ically disposed.12• 13 In accord with the alignment of light and heavy chains,
`corresponding intrachain disulfide bonds are in similar positions and the disulfide
`loops are of approximately the same size.
`Previous studies7 have suggested that V regions of light and heavy chains have
`similar lengths and begin at the NHrtermini; this will be confirmed below.
`The CL region of the light chain has the same length as V L, but the CH region of
`the heavy chain is about three times as long. CH may be divided into three
`
`2 of 8
`
`BI Exhibit 1091
`
`

`

`80
`
`BIOCHEMISTRY: EDELMAN ET AL.
`
`PROC. N. A. s.
`
`homologous regions of approximately equal length: Cul, C82, and C83 (Fig. 1).
`We have already reported the amino acid sequence of the first 877 and the last
`224 residues8 of the heavy chain as well as the partial sequence of the entire light
`chain.6 The complete amino acid sequence of the light chain (214 residues) is
`shown in Figure 2. Positions of the half-cystiuyl residues may be compared
`with Figure 1 and the methionyl residues may be correlated with previous studies
`on the CNBr fragments of Eu.3• 4 The variable region extends through residue
`108. In accord with other studies,1 valine 191 is related to the Inv specificity. 2
`The complete sequence of the heavy chain (446 residues) is presented in Figure
`3 which may be compared with Figure 2 for alignment with the light chain
`sequence. Isolation of a single glycopeptide8 indicated that the polysaccharide
`
`10
`20
`l
`ASP-I LE-GLN-MET-THR-GLN-SER-PRO-SER-THR-LEU-SER-ALA -SER ·VAL· GL Y-ASP-ARG-VAL -THR-
`
`40
`30
`ILE-THR-� ARG-ALA-SER-GLN-SER-ILE-ASN-THR-TRP-LEU-ALA-TRP·TYR-GLN-GLN-LYS-PR0-
`60
`50
`GLY-LYS-ALA-PRO-LYS-LEU-LEU-MET-TYR-LYS-ALA-SER-SER-LEU-GLU·SER·GLY-VAL-PRO·SER·
`
`80
`70
`ARG-PHE-ILE-GLY-SER-GLY-SER-GLY-THR-GLU-PHE-THR-LEU-THR-ILE-SER-SER-LEU-GLN-PR0-
`
`90
`100
`ASP·ASP-PHE·ALA-THR-TYR·TYR-�-GLN-GLN-TYR-ASN-SER-ASP-SER-LYS-MET-PHE-GLY-GLN-
`110
`120
`GLY·THR·LYS-VAL-GLU-VAL-LYS·GLY·THR-VAL·ALA-ALA-PRO-SER-VAL-PHE-ILE-PHE-PRO-PRO-
`
`130
`140
`SER-ASP-GLU-GLN-LEU-LYS-SER-GLY-THR-ALA-SER-VAL-VAL-�-LEU-LEU-ASN-ASN-PHE-TYR-
`150
`160
`PRO-ARG-GLU·ALA-LYS-VAL-GLN-TRP·LYS-VAL·ASP-ASN-ALA-LEU-GLN-SER-GLY-ASN-SER·GLN·
`
`170
`180
`GLU-SER-VAL·THR-GLU·GLN-ASP-SER·LYS·ASP-SER-THR-TYR-SER-LEU-SER-SER·THR-LEU·THR·
`
`190
`200
`LEU·SER·LYS-ALA·ASP·TYR·GLU-LYS-HIS-LYS-VAL-TYR-ALA-� GLU-VAL-THR-HIS-GLN-GLY·
`210
`214
`LEU-SER· SER-PRO-VAL-THR-L YS-SER -PHE-ASN-ARG· GLY· GLU-�
`
`FIG. 2.-Complete amino acid sequence of the Eu light cha.in. Ha.lf-cystinyl residues a.re in
`boxes and methionyl residues a.re underlined.
`
`portion of the molecule is attached at Asx residue 297.14 In a previous study8 we
`have suggested that glut.amyl residue 356 and methionyl residue 358 may be
`associated with Gm 1 specificities. The sequence of Eu (Gm 4+) between
`residues 211-252 can be compared with the partial sequence of immunoglobulin
`Daw17 (Gm 4-). The presence of arginine in position 214 of Eu and lysine in a
`comparable position of Daw may be ru380ciated with their Gm 4 specificities.18
`Of particular significance is the determination of the point at which Va ends
`and Ca begins. A CNBr fragment comparable to fragment H4 was isolated
`from myeloma protein He which has the same Gm specificity as protein Eu. The
`sequence of the amino terminal portion of the CNBr fragment from He differed
`from that of the H. fragment from Eu. 21
`
`3 of 8
`
`BI Exhibit 1091
`
`

`

`VOL. 63, 1969
`
`BIOCHEMISTRY: EDELMAN ET AL.
`
`81
`
`1
`10
`20
`PCA·VAL·GLN·LEU·VAL·GLN·SER·GLY·ALA·GLU·VAL·LYS·LYS·PRO·GLY·SER·SER·VAL·LYS·VAL·
`30
`40
`SER-�· L YS·ALA· SER· GLY • GLY • THR · PHE ·SER ·ARC· SER ·ALA· I LE· I LE· TRP-VAL • ARG· GLN. ALA·
`60
`50
`PRO· GL Y · GLl'.J • GLY· LEU· GLU · TRP· �-GLY· GLY ·I LE·VAL ·PRO-MET ·PHE ·CLY· PRO· PRO· ASN · TYR ·
`70
`80
`ALA·GLN·LYS·PHE·GLN-GLY·ARG·VAL·THR· ILE·THR·ALA·ASP·GLU·SER·THR·ASN·THR·ALA-TYR·
`90
`100
`�1ET • GLU·LEU· SER· SER ·LEU· ARG ·SER· GLU·ASP· THR ·ALA· PHE · TYR · PHE ·§ ALA· GLY· GLY • TYR •
`110
`120
`CLY· ILE·TYR·SCR·PRO·GLU·GLU·TYR·ASN·GLY·GLY·LEU·VAL·THR·VAL·SER-SER·ALA·SER·THR·
`130
`140
`LYS·GLY·PRO·SER-VAL-PHE·PRO·LEU·ALA·PRO·SER·SER·LYS-SER-THR-SER·GLY·GLY·THR-ALA·
`150
`160
`ALA- LEU· GLY ·§ LEU· VAL· L VS ·ASP· TYR ·PH£ -PRO· GLU· PRO·VAL • THR ·VAL· SER-TRP-ASN· SER·
`170
`130
`GLY·ALA·LEU·THR·SER·GLY·VAL·HIS-THR-PHE-PRO·ALA·VAL-LEU·GLN·SER·SER·GLY-LEU-TYR·
`
`190
`�
`SER· LEU· SER· SER· VAL· VAL· THR ·VAL· PRO· SER· SER· SER -LEU· GLY-THR · GLN • THR · TYR • I LE·�
`210
`�
`ASN ·VAL ·ASN ·HIS· LYS ·PRO· SER -ASN · THR· LYS·VAL • ASP·LYS ·ARG ·VAL· GLU· PRO-LYS· SER-�
`230
`240
`ASP-LYS · THR · ltl S • TltR -�·PRO· PRO-�· PRO· ALA· PRO· GLU· LEU· LEU·GLY· GLY ·PRO· SER ·VAL·
`250
`260
`PHE ·LEU-PHE ·PRO· PRO· L VS· PRO ·l VS ·ASP· THR ·LEU· MET-I LE -SER -ARG-THR-PRO· GLU·VAL • THR •
`
`2SO
`270
`� VAL·VAL·VAL-ASP-VAL-SER-HIS·GLU·ASP·PRO·GLN·VAL-LYS·PHE·ASN-TRP·TYR-VAL-ASP·
`290
`300
`GLY-VAL-GLN-VAL-HIS-ASN·ALA·LYS-THR·LYS-PRO-ARG-GLU·GLN-GLN-TYR-ASX-SER·THR·TYR·
`
`320
`310
`ARG·VAL·VAL·SER-VAL-LEU·THR-VAL·LEU-HIS-GLN-ASN-TRP-LEU-ASP-GLY-lYS-GLU-TvR-LYS·
`330
`340
`§ Lv5-VAL·SER·ASN·LYS·ALA·LEU-PRO-ALA-PR0-IL£-GLU-LYS·THR-ILE-SER-LYS·ALA-LYS-
`360
`350
`GL Y · GLN ·PRO· ARG • GLU ·PRO· GLN-VAL · TYR -THR -LEU-PRO· PRO-SER -ARG-GLU • GLU· MET-THR -LYS-
`370
`380
`ASN · GLN· VAL· SER-LEU· THR ·(@ LEU· VAL· LYS· GL Y· PHE · TYR -PRO· SER ·ASP· I LE ·ALA-VAL ·CLU·
`400
`390
`TRP-GLU·SER·ASN-ASP-GLY·GLV·PRO·GLV·ASN·TYR·LYS·THR·THR-PRO·PRO·VAL-LEU·ASP·SER-
`420
`410
`ASP·GLY·SER·PHE·PHE·LEU-TYR·SER·LYS·LEU·THR-VAL·ASP-LYS-SER-ARG-TRP·CLN-GLU·GLY-
`440
`430
`ASN ·VAL· PHE ·SER-�-SER -VAL· MET· HIS· GLU· ALA· LEV· HI S-ASN-H I S-TYR-THR· GLN-L vs-SER·
`446
`LEV· SER· LEU-SER -PRO· GLY
`
`Ft0. 3.-Complcte amino acid sequence of the Eu heavy chain. Half-cystinyl residues are in
`boxes and methionyl residues are underlined.
`
`A comparison of the sequence of the two fragments from residues 101 to 121
`is given in Figure 4. The sequences become identical at residue 115 (Eu num­
`bering). Further studies21 confirmed that from residue 115 to residue 252 the
`sequence of the He fragment was identical to that of Eu H.. In addition,
`tryptic fingerprints of the Fe fragments from Eu and He were identical. These
`
`4 of 8
`
`BI Exhibit 1091
`
`

`

`UIOCHEMIS'l'llY: EDEJ,MAN ET Af,.
`
`PROC. N. A. s.
`
`EL
`
`120
`115
`110
`105
`101
`·GLY·ILE·TYR·SER-PRO-GLU·GLU·TYR-ASN-GLY·CLY·LEU·VAL·THR·VAL·SER·SER·ALA·SER·THR·LYS·
`
`H(
`
`· THR ·LEU -ALA· PHE ·ASX -VAL· TRP· Gl Y · GLX · Gl Y · THR -LYS· VAL· ALA· VAL· SCR ·SER ·ALA· SER· THR· l YS·
`
`F1<;. 4.-Cornparison of the am ino acid sequence of !he En heavy chain from re:<i<lue 101-121
`with the corre.�ponding seq11e11ce
`
`of the heavy rhain of myeloma protein He.
`
`data suggest that the transition between Vu and C11 is located in the vicinity of
`residue 114 (Eu numbering). Studies on a number of additional proteins and a
`search for Vn region subgroups7 will be required to locate this point definitively.
`Discussion.-The present studies provide proof of the covalent structure and
`arrangement of chains in -yGl immunoglobulin. The half-molecule of Eu is the
`largest protein unit (446 + 214 residues) for which a complete amino acid
`sequence has been determined. In a protein of this size, one cannot neglect the
`possibility of small errors in sequence assignment; for this reason we arc carrying
`out a number of further checks using varioui:; methodi:; of peptide cleavage and
`fractionation.
`One of the most striking features of the immuuoglobulin molecule that emerges
`from the completed sequence is the sharp demarcation of its polypeptide chains
`into linearly connected regions that are associated with different. functions.
`Variations in the sequences of paired VH and V L regions for the function of
`antigen binding in the selective immune response, and at the same time, conser­
`vation of sequence in Cn and CL regions for other immunological functions appear
`to require special genetic and evolutionary mechanisms. 22
`The amino acid sequence of Eu provides convincing evidence that. the immuno­
`globulin molecule evolved by successive duplication of precursor genes. 23• 24 Our
`analysis of a complete heavy chain ha:s revealed an :idditional homology region
`(CHl), the structure of which was not previously known. Earlier comparisons7• 8
`of polynucleotide sequences corresponding to both chains of Eu showed evidence
`of homology between Vu and V L and homologies among Cr., Cn2, and CH3. A
`complete comparison of the amino acid sequences of CL, CHl, Cn2, and Cu3 is
`In a stretch of 100 residues, any two regions are identical in
`given in Figure 5.
`29 to 34 positions. It is noteworthy that the stretch in the heavy chain from
`residue 221 to 233 which contains the interchain disulfide bonds; hai:; no homol­
`ogous counterpart in other portions of heavy or light chains.
`In the data accumulated so far, little or no homology has been found between
`V and C regions. This prompts the speculation that V genes and C genes
`diverged early in the evolution of antibodies to serve two major groups of func­
`tions: antigen recognition functions (ARF) and effector functions (BF) such as
`interaction with cells and complement. The order of emergence of Cr, genes or
`CH genes from a precursor gene is not apparent from the data. A comparison
`with sequences ofµ, a, o, or E chains may indicate similarities in their Vu regions25
`and may show whether any of the homology regioni:; are conserved in constant
`regions of heavy chains of these classes. 26
`Early evolutionary divergence of V and C genes i:-; consistent with the evi­
`dence27 · 28 that each chain is specified by two genes, V and C, and the hypothe­
`sis7· 22· 29 that V gene episomcs nrc translocated to C genes to form a single VC
`
`5 of 8
`
`BI Exhibit 1091
`
`

`

`VoL. Ga, 1969
`
`WOCHEMISTRY: EDELMAN ET AL.
`
`83
`
`<RESIDUES 109-214>
`
`EU C
`L
`EU C
`l <RESIDUES 119-220)
`H
`2 <RESIDUES 234-341)
`EU C
`H
`3 tRESIDUES 342-44bl
`EU C
`H
`
`110
`THR VAL ALA ALA PRO SElt
`SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO
`
`120
`I LE PHE PRO PRO
`
`LEU LEU GL Y GL Y PRO SER VAL PHE LEU PHE PRO PRO LVS
`
`GLH PRO ARG GLU PRO GLH VAL TYR THR LEU PRO PRO SER
`
`130
`LEU LYS SER GLY THR ALA SER VAL VAL CVS LEU LEU ASN ASH PHE
`
`ASP GLU GLN -
`SER LYS SER -
`THR SER GLY GLV THR AL.\ ALA LEU CLY CVS LEU
`PRO LYS ASP THR LEU MET I LE SER ARG THR PRO GLU VAL THR CVS
`ARG GLU GLU -
`MET THR LVS ASH GLH VAL SER LEU THR CVS
`
`LYS ASP TYR
`
`VAL ASP VAL
`
`LYS GLY PHE
`
`PRO ARG GLU ALA LYS VAL -
`PRO GLU PRO VAL THR VAL -
`
`150
`GLN TRP LYS VAL .\SP ASN A
`
`GLN SE
`
`SER TRP ASN SER - GLV ALA LEU THR SER GL V
`
`HIS GLU ASP PRO GLN VAL LYS PHE ASN TRP TYR \l.\L ASP GLV - VAL GLN VAL HIS
`PRO SER ASP I LE ALA VAL -
`
`GLU TRP GLU SER ASN ASP -
`
`GL Y GLU PRO GLU
`
`170
`lbO
`SER GLN GLU SER VAL THR GLU CLN ASP SER LVS ASP SER THR TYR SER LEU SER SER
`- VAL HIS THR PHE PRO ALA VAL LEU GLN SER - SER GLV LEU TYR SER LEU SER SER
`SN ALA L VS THR L YS PRO ARC CLU CLN GLN TYR - ASP SER THR TYR ARC VAL VAL SER
`S1j TYR LVS THR THR PRO PRO VAL LEU ASP SER -
`SP CLY SER PHE PHE LEU TYR SER
`
`190
`180
`THR LEU THR LEU SER LYS ALA ASP TYR CLU LYS HIS L VS VAL TYR ALA CVS CLU VAL THR
`\'AL VAL THR \/AL PRO SER SER SER LEU CLY THR CLN - THR TYR ILE CVS ASN VAL ASN
`l\L LEU THR V.\L LEU HIS CLN ASN TRP LEU ASP CLV L VS CLU TYR L VS CVS LYS VAL SER
`LYS LEU THR VAL ASP LVS SER ARC TRP CLN CLU GLV ASN VAL PHE SER CVS SER \/AL MET
`
`200
`CLN CLY LEU SER SER PRO VAL 'THR - LYS SER PHE -
`LYS PRO SER ASN THR LYS VAL -
`ASP L VS ARG VAL -
`CLU PRO LYS SER CVS
`ASN LYS ALA LEU PRO ALA PRO I LE - GLU L VS THR I LE SER LVS ALA LYS GL �
`GLU ALA LEU HIS ASN HIS TYR THR CLN l VS SER LEU SER LEU SER PRO C.C V
`
`210
`ASN ARC CLV GLU CVS
`
`-
`
`FJG. :3.-Comparisoo of t.he amino acid sequence of CL, C:�l, CH2, and CH3. Deletfons
`indi­
`cat.ed by dashes have been inl.roduced to maximize the homology. Identical residues are darkly
`shaded; both dark and light. shading are nsed lo indicate identitie:< which occur in pairs in the
`Rame positions.
`
`gene in lymphoid cell precursors. Dreyer and Bennetta.> have previously sug­
`
`
`
`of C genes and, more recently,
`this has been abandoned in
`gested a translocation
`
`31 Translocation of genes may be the
`
`
`favor of a detailed "copy-splice" mechanism.
`
`
`
`
`basis of the phenomena of clonal expression and allelic exclusion in antibody
`
`
`Irreversible differentiation and commitment of a lymphoid pre­
`production.
`cursor cell may thus occur at the time of gene translocation.
`
`
`The alignment of disulfide bonds, the arrangement of symmetry axes, and the
`
`fact that proteolytic enzymes cleave the molecule to produce Fab, Fe and Fe'
`
`fragments32 suggest that each homology region may be folded in a compact
`
`
`domain29 stabilized by a single intrachain disulfide bond and linked to neighbor­
`
`
`ing regions by less tightly folded stretches of polypeptide chain. Such domains
`
`
`
`would have similar but not identical tertiary structures, and each domain would
`
`6 of 8
`
`BI Exhibit 1091
`
`

`

`84
`
`BIOCHEMISTRY: EDELMAN ET AL.
`
`PROC. N. A. 8.
`
`contribute to at least one active site mediating a function of that class of im­
`munoglobulin. This domain hypothesis is consistent with the hypothesis that
`the molecule evolved by gene duplication as well as with the translocation
`hypothesis. As mentioned above, comparison of the structure and function of
`CH regions in different immunoglobulin classes should reveal whether addition or
`deletion of homology regions and corresponding domains is a major mechanism
`in the evolution of these classes.
`Support for the domain hypothesis would come from finding that limited
`proteolysis of Fab fragments yields fragments containing halves of the Fd frag­
`ments. Similar treatment of Bence-Jones proteins may produce V L and CL
`fragments.33 Additional evidence may come from location in Cu of sites for
`complement fixation and skin fixation. Final proof or disproof of this hypothesis
`obviously rests on the results of X-ray crystallographic analysis.
`It is clear
`that a rotation axis passes through the disulfide bonds linking the heavy chains
`and there may be an axis of pseudosymmetry between the light and heavy chains.
`The locations of the interchain and intrachain disulfide bonds, the extensive
`homologies, and the alignment of the light and heavy chains with each other
`suggest that the overall relationships described above will be conserved in the
`three-dimensional structure regardless of the details of folding.
`The exact contribution of the variable regions to the antigen combining site
`must also await analysis of the three-dimensional structure.
`It is known that the
`Fab fragment contains both V L and V H regions, and affinity-labeling experi­
`ments21 indicate that tyrosyl residues34• 3� in these regions are directly involved
`in antigen binding. The constancy of the disulfide bonds in VH and V L regions
`and their coordinate location suggest the possibility that the site is fixed by these
`bonds and that variations in the branches of a chain connected by each bond
`may be sterically arranged around the bond as a center. The closely homologous
`CL and Cttl regions may serve additionally to stabilize the structure in the face of
`the variation, so that both V Land V H can participate in the site.
`In contrast to the diversity of V regions, the origin of which is still unknown, 22
`the C regions appear to be quite stable in various animal species. Recent
`studies8 show striking resemblances in the Fe portions of rabbit23 and human
`'YG immunoglobulin.
`In this respect, C regions, like enzymes, may have evolved
`to interact with specific molecules, e.g., those of the complement system. The
`presence of genetic differences in C regions has not so far been related to their
`function, but there is no reason to expect that the origin of variations in C regions
`will differ from other genetic polymorphisms.
`
`We are deeply indebted to Dr. Jack Brook for supplying Eu plasma. We are grateful
`to Miss Joan Low, Miss Catherine Volin, and Mrs. Hclvi Hjelt for their expert technical
`assistance.
`
`•Supported by grant GB 6546 from the National ScienC'c Foundation and by grant AM
`04256 from the N a.tional Institutes of Health.
`1 For a general review, see Cold Spring Harbor Symposia on Quantitative Biology, vol. 32
`(1967), and Nobel Symposium S: Gamma Globulins, St.ruclure and Control of Biosynthesis, ed.
`J. Killander (Stockholm: Almqvistand Wiksell, 1967).
`z Edelman, G. M., W. E. Call, M. J. Waxdal, and W. H. Konigsberg, Biochemistry, 7, 19!i0
`(1968).
`
`7 of 8
`
`BI Exhibit 1091
`
`

`

`VOL. 63, 1969
`
`BIOCHEMISTRY: EDELMAN ET AL.
`
`85
`
`a Waxdal, M. J., W. H. Koniy;;berg, W. L. Henley, anti G. M. Edelman, Biochemistr-y, 7, l!J.iH
`(1968).
`• Waxdal, M. J., W. H. Koni�berg, 1111rl G. M. Edelman, Biochemistry, 7, 1967 (1!�68).
`•Gall, W. E., B. A. Cunningh11.m, l\l. J. Waxd11.l, W. H. Konig>;berg, and U. M. Edelman,
`Biochemistry, 7, 1973 (1968).
`6 Cunningham, B. A., P. D. Gottlieb, W. H. Konigi;berg, and G. M. Edelman, Biochemistry,
`7, 1983 (1968).
`7 Gottlieb, P. D., B. A. Cunningham, M. J. Waxdal, W. H. Konigsberg, and G. M. Edelman,
`61, 168 (1968).
`these PROCEEDINGS,
`a Rutishauser, U., B. A. Cunningham, C. Bennett, W. H. Konigsberg, and G. M. Edelman,
`
`these PROCEEDINGS, 611 1414 (1969).
`9 Bennett, C., W. H. Konigsberg, and G. M. Edelman, manuscript in preparation.
`10 Gall, W. E., and G. M. Edelman, manuscript in preparation.
`11 Brown, J. R., and B. S. Hartley, Biochem. J., 101, 214 (1966).
`11 Waxdal, M. J., W. H. Konigsberg, and G. M. Edelman, in Cold Spring Harbor Symposia tm
`Quantitative Biology, vol. 32, 53 (1967).
`u Pink, J. R. L., and C. Milstein, Nature, 216, 941 (1967).
`14 Inasmuch as the mechanism of attachment of the carbohydrate is unknown, we have not
`specified whether residue 297 is Asp or Asn. This residue begins the tripeptide sequence Asx­
`Ser-Thr (residues 297-299), which is the same as the Asx-X-Thr sequence found at the point
`of attachment of the carbohydrate portion of several other glycoproteins. 16• 16
`16 Eylar, E. H., J. Theoret. Biol., 10, 89 (1966).
`14 Catley, B. J., S. Moore, and W. H. Stein, J. Biol. Chem., 244, 933 (1969).
`11 Steiner, L. A., and R.R. Porter, Biochemistry, 6, 3957 (1967).
`1• The association with Gm 1 specificities is based on definitive studies. 11• •0 Additional
`evidence is required for the correlation of sequence variation with Gm 4 specificities.
`11 Thorpe, N. 0., and H.F. Deutsch, Immunochemistry, 3, 329 (1966).
`20 Frangione, B., C. Milstein, and J. R. L. Pink, Nature, 221, 145 (1969).
`ii Cunningham, B. A., M. Pflumm, U. Rutishauser, and G. M. Edelman, manuscript in
`preparation.
`u Edelman, G. M., a.ndJ. A. Gally, in Brookhaven Symposia in Biology, No. 21, 328 (1968).
`u Hill, R. L., R. Delaney, R. E. Fellows, Jr., and H. E. Lebovitz, these PROCEEDINGS,
`56,
`1762 (1966).
`u Singer, S. J., and R. F. Doolittle, Science, 153, 13 (1966).
`16 Wikler, M., H. Kohler, T. Shinoda, and F. W. Putnam, Science, 163, 75 (1969).
`ie For generality, we have used CL and Cal, C82, etc., to designate homology regions. If
`such regions are found in other classes, a more specific nomenclature, e.g. C,., C-yl, C,,2, etc., and
`perhaps C,.1, etc., may be required. The same obviously holds for V regions.
`27 Hood, L., and D. Ein, Nature, 220, 764 (1968).
`28 Milstein, C., C. P. Milstein, and A. Feinstein, Nature, 221, 151 (1969).
`29 Edelman, G. M., and W. E. Gall, Ann. Rev. Biochem., 38, (1969), in press.
`ao Dreyer, W. J., andJ. C. Bennett, these PROCEEDINGS,
`54, 864 (1965).
`11 Dreyer, W. J., W.R. Gray, and L. Hood, in Cold Spring Harbor Symposia tm Quantitative
`Biology, vol. 32, p. 353 (1967).
`u Turner, M. W., and H. Bennich, Biochem. J., 107, 171 (1968).
`u Berggll.rd, I., and P. Peterson, in Nobel Symposium S: Gamma GWlru.lins, Structure and
`Control of Biosynthesis, ed. J. Killander (Stockholm: Almqvist and Wiksell 1967), p. 71.
`
`u Singer, S. J., and N. 0. Thorpe, these PROCEEDINGS, 60, 1371 (1968).
`u Although there are no direct data on affinity labeling of human antibodies, by analogy (see
`ref. 24), we would suggest that tyrosyl residues 86 of the light chain and 94 of the heavy chain
`may have a function in the active site.
`
`8 of 8
`
`BI Exhibit 1091
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket